Sponsor:
Xijing Hospital
Code:
NCT07492927
Conditions
Clinically Significant Prostate Cancer
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Brief summary:
Conditions
Clinically Significant Prostate Cancer
Study ID
NCT07492927
Start date
Mar 12, 2021
Status verified date
Mar, 2026
Completion date
Jun 30, 2027
Anticipated
Primary completion date
Dec 31, 2026
Anticipated
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
1700 participants
Anticipated
Arms
Study Cohort
Primary outcome measure
Central contacts
Locations
Northwestern Memorial Hospital
Recruiting
Chicago, Illinois, United States, 60611
Contacts
Principal Investigator:
Qiang Zhang, MD.
Sponsor
Xijing Hospital
Last update posted
Mar 25, 2026
Last verified
Mar, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Xijing Hospital on 2026-03-25.